This review highlights the utility of the TGR(ASrAOGEN) transgenic rat model in demonstrating the causative role of the brain renin-angiotensin system in stress-induced renin release.
Answers are grounded in this paper and cite their sources.
Supports brain RAS in stress renin release via rat models; leaves open clinical translation and human relevance.
The advance of genetic technologies to permit tissue-specific targeted gene manipulation allowed the development of transgenic models with alterations of the renin-angiotensin (RAS) solely in the brain. We have used such methodology to develop a transgenic rat with a brain specific alteration of the RAS [TGR(ASrAOGEN)], in order to elucidate a causative role for the brain RAS and its relevance in different pathophysiological processes. The TGR(ASrAOGEN) rats have decreased levels of angiotensinogen (AOGEN) throughout the brain because of an antisense inhibition of the astroglial AOGEN synthesis. In this review we aimed at summarizing the experience obtained from utilizing the TGR(ASrAOGEN) rat model to study the brain RAS and present novel results providing evidence for the involvement of this system in stress-induced renin release.
No takes yet. Share an insight, caveat, or question.
Baltatu et al. (2004) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: